Healthcare Industry News: Silicon Nitride
News Release - August 6, 2009
Ben Shappley Joins Amedica's Leadership TeamSALT LAKE CITY, Aug. 6 -- (Healthcare Sales & Marketing Network) -- Amedica Corporation, a spinal and orthopaedic implant company focused on Silicon Nitride ceramic technologies, announced today that Ben Shappley has joined the Company as its Chief Executive Officer and President. Mr. Shappley will also serve on the company's Board of Directors.
"Our Board of Directors and Management team are pleased to extend a warm and enthusiastic welcome to Ben in his role at Amedica," said Max Link, Ph.D., Chairman of Amedica Corporation. "We believe his extensive experience in the spine and orthopaedic industries will provide significant skills to grow our spinal and orthopaedic implant business."
"It is my pleasure to welcome Ben to Amedica," said Ashok C. Khandkar, Ph.D., Vice Chairman of Amedica Corporation. "With Ben joining our team and leading operations and commercialization efforts, our business and technical leadership will be better positioned for success in the years ahead. This will free me to concentrate my efforts to developing and expanding Amedica's unique Silicon Nitride technology. I also look forward to devoting more time to broaden the portfolio of new and exciting products for the orthopaedic industry."
"I am pleased to be a part of Amedica, its significant and important technologies and successful management team. I believe that Amedica's advanced and heavily-patented Silicon Nitride ceramic technologies will play a continuing major role in cost-effective, improved spinal patient care," said Mr. Shappley.
Amedica Corporation is an emerging orthopaedic implant company focused on using its Silicon Nitride ceramic technologies to develop and commercialize a broad range of innovative, high-performance spine and joint implants for the growing orthopaedic device market. It has brought to market various spinal implant products, while products under development include reconstructive hip and knee implants that may represent a new standard of care in total joint implants based on superior disability performance and safety.
Source: Amedica Corp
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.